Mather Group »

Cue Biopharma shares owned by Mather Group

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Mather Group from 13F filings

Historical chart of Mather Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Mather Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Mather Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $719 1.0k 0.72
2025-03-31 $911 1.0k 0.91

More positions owned by Mather Group

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Lennox International (LII)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Spdr Series Trust Portfli Intrmdit (SPTI)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust Intl Small Cap V (DISV)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Spdr Series Trust Portfolio Ln Tsr (SPTL)

View all positions for Mather Group

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Advisory Research
Renaissance Technologies
UBS Group
Stifel Financial
State Street Corporation
Susquehanna International
Angeles Wealth Management
Northern Trust

View all funds holding Cue Biopharma